Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Clinical Services Laboratory, |
RCV000375532 | SCV000479550 | uncertain significance | Hyper-IgE syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000693678 | SCV000821556 | uncertain significance | Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive | 2018-03-26 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with methionine at codon 184 of the DOCK8 protein (p.Val184Met). The valine residue is moderately conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs143461644, ExAC 0.2%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals with DOCK8-related disease. ClinVar contains an entry for this variant (Variation ID: 366544). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |